Skip to contentL
LifeMD, Inc.
L
LFMDLifeMD, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$6.75M$6.75Mderived−85.0% vs Q4 2023 Net Income-$3.11M-$3.11MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
LifeMD, Inc. · CIK 948320 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$56,494N/M Operating Incomederived-$3,928,903N/M Operating Cash Flowderived$1,073,301−81.2% Free Cash Flowderived$875,391−84.4% Margins · derivedGross margin-0.8%−88.9 pt vs Q4 2023
Operating margin-58.2%−53.4 pt vs Q4 2023
Net margin-46.1%−37.7 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 11, 2025 · 70 d after period end